OptiTROP-Lung06 showed statistically significant and clinically meaningful progression-free survival improvement versus pembrolizumab plus pemetrexed and platinum chemotherapy, with a positive overall survival trend at interim analysis.
verifying reliability
No specialized terms available for this topic.